CompanyAnalyst RatingCurrent PricePrice TargetBeam Therapeutics (BEAM)BUY$32.13$55Implied UpsideMarket CapNet Cash/ShareCash Runway+71%$3.26B$12.20Into 2029The Market Dislocation: Beam Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results